Unlock instant, AI-driven research and patent intelligence for your innovation.

Use of natural compound as anti-diabetes drug

A technology of diabetes drugs and compounds, which is applied in the application field of 4-hydroxymelphenytoin in the preparation of drugs for treating diabetes, and can solve the problems that there are no research reports on the anti-diabetic effect of 4-hydroxymelphenytoin

Active Publication Date: 2015-05-27
TSINGHUA UNIV +1
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, for diabetes (especially type 2 diabetes), there is no research report on the antidiabetic effect of 4-hydroxymelphenytoin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of natural compound as anti-diabetes drug
  • Use of natural compound as anti-diabetes drug
  • Use of natural compound as anti-diabetes drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Embodiment 1 regulates the effect of phase secretion of insulin

[0038] Scheme and implementation: With reference to the detection of the effect of 4Q on the survival rate of this kind of cells, the low and high doses of 4Q were selected as 0.1 and 30 μM, respectively.

[0039] Rin-5f islet β cells were inoculated in 100mL culture dish (10 7 cells / well) after 24 hours of culture, the cells were cultured with high glucose 1640 medium (glucose content of 16.4mM). According to different treatments, they were divided into high glucose model group and 4Q low, middle and high dose groups. Under high glucose environment, 4Q acted for 15min, 60min and 120min respectively. Afterwards, 100 μL of the culture supernatant was taken, and the insulin content in the culture supernatant was detected, and the measurement unit of insulin was represented by International Viability Unit (IU, 1IU=45.4 μg).

[0040] Experimental results: In a high-glucose environment (medium with a glucos...

Embodiment 2

[0041] Example 2 Improving the Effect of Glucose Consumption in the Insulin Resistance Model

[0042] Scheme and implementation: With reference to the detection of the effect of 4Q on the survival rate of this kind of cells, the low, medium and high doses of 4Q were selected as 0.1, 1 and 10 μM respectively.

[0043] Establishment and testing of insulin resistance model: set up 2 groups, normal glucose and normal insulin group, high glucose and high insulin group, 6 samples in each group. Adipocytes were cultured in low-sugar DMEM medium (containing 5.5 mM glucose) containing 1% BSA for 12 hours, and then intervened in groups. The normoglucose normoinsulin group contained 1%BSA, 5.5mM glucose, 10 -9 The DMEM medium of M insulin was cultivated; the high glucose and high insulin group contained 1% BSA, 25mM glucose, 10 -6 M insulin was cultured in DMEM medium. After 24 hours of intervening culture, the culture medium was discarded, washed with PBS for 3 times, and the glucose...

Embodiment 3

[0046] Example 3 Detection of the toxicity of Rin-5f to pancreatic islet β cells and 3T3-L1 adipocytes

[0047] Protocol and implementation: Rin-5f islet β cells and 3T3-L1 adipocytes were seeded in 96-well plates (10 4 cells / well), after culturing for 24 hours, add different concentrations of 4Q (final concentrations are 1, 3, 5, 10 μM), set up three parallel wells for each concentration, control group without drug treatment, put them in the incubator for incubation 24h. Then add 10 μL of freshly prepared MTT (final concentration 5 mg / mL) solution, incubate for 4 h, pour off the supernatant, add 200 μL of DMSO (dimethyl sulfoxide) to each well, and measure the optical density at 570 nm (OD ).

[0048] Experimental results: if Figure 3A and 3B Shown are the toxicity test results of different concentrations of 4-hydroxymephenytoin on Rin-5f pancreatic beta cells and 3T3-L1 adipocytes in this example. The toxicity of -5f islet β cells and 3T3-L1 adipocytes is small, and th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a use of 4-hydroxymephenytoin in preparation of a drug for treating diabetes and relates to a use of the compound shown in the formula I or its pharmaceutically acceptable salt, solvate, polycrystal, enantiomer or racemic mixture in preparation of an anti-diabetes drug. An in-vivo experiment proves that the 4-hydroxymephenytoin compound can promote and adjust insulin time phase secretion and improve insulin resistance and has a diabetes treatment function. The compound is derived from traditional Chinese medicine and has a good research and development prospect.

Description

technical field [0001] The invention belongs to the field of antidiabetic drugs, and in particular relates to the application of 4-hydroxymephenytoin in the preparation of drugs for treating diabetes. Background technique [0002] According to statistics, diabetes is an endocrine and metabolic disease characterized by hyperglycemia, and its main risk factors include heredity, abnormal pancreatic β-cell function, obesity, hyperlipidemia, hypertension, smoking and alcoholism, and environmental pollution (Yang W , et al. New England Journal of Medicine, 2010.; Li Jing. Chinese Medicine Guide, 2012.; Zhang Xiaoxia. Shandong University Master Thesis, 2013.). The latest data show that the number of people suffering from diabetes in my country is nearly 100 million. Among them, the prevalence of diabetes has reached 11% in cities, towns and wealthy rural populations over the age of 20, and another 15% have impaired blood sugar regulation. Diabetes has become a major public health p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4174A61P3/10
Inventor 李梢仝小林李慧颖赵林华
Owner TSINGHUA UNIV